ES2054207T3 - Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores. - Google Patents

Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores.

Info

Publication number
ES2054207T3
ES2054207T3 ES90125244T ES90125244T ES2054207T3 ES 2054207 T3 ES2054207 T3 ES 2054207T3 ES 90125244 T ES90125244 T ES 90125244T ES 90125244 T ES90125244 T ES 90125244T ES 2054207 T3 ES2054207 T3 ES 2054207T3
Authority
ES
Spain
Prior art keywords
cyclosporin
phenylaminovaleronitrils
isopropil
vasodilators
immunosuppressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90125244T
Other languages
English (en)
Inventor
Liang Chi-Dean
Richard August Mueller
Kearn John P Mc
Terry B Strom
Kenneth J Wieder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2054207T3 publication Critical patent/ES2054207T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

VALERONITRILOS DE 2-ISOPROPIL-2-FENIL-5-(FENETIL AMINO) SUSTITUIDOS SON UTILIZADOS COMO INMUNOSUPRESORES EN UN METODO PARA EL TRATAMIENTO DEL RECHAZO DE ORGANOS TRANSPLANTADO, BIEN POR SI SOLOS O JUNTO CON LA ADMINISTRACION DE CICLOPORINA DE MANERA SINERGISTICA QUE PERMITE MENORES DOSIS DE CICLOSPORINA QUE LAS QUE SE SUMINISTRARIAN SI LA CICLOSPORINA FUERA ADMINISTRADA POR SI SOLA. EL MECANISMO DE ACCION ESTA PENSADO PARA QUE SEA INDEPENDIENTE DEL CANAL DE CALCIO CARDIOVASCULAR QUE BLOQUEA LA ACTIVIDAD DE LOS COMPUESTOS.
ES90125244T 1989-12-21 1990-12-21 Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores. Expired - Lifetime ES2054207T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45600789A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
ES2054207T3 true ES2054207T3 (es) 1994-08-01

Family

ID=23811068

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90125244T Expired - Lifetime ES2054207T3 (es) 1989-12-21 1990-12-21 Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores.

Country Status (10)

Country Link
EP (1) EP0434094B1 (es)
JP (1) JPH04210632A (es)
AT (1) ATE87614T1 (es)
CA (1) CA2033038A1 (es)
DE (1) DE69001240T2 (es)
DK (1) DK0434094T3 (es)
ES (1) ES2054207T3 (es)
GR (1) GR3008320T3 (es)
IE (1) IE64870B1 (es)
PT (1) PT96283A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5421908B2 (ja) 2007-06-20 2014-02-19 マイルストーン ファーマシューティカルズ インコーポレーテッド 短時間作用型フェニルアルキルアミンカルシウムチャネルブロッカーおよびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
PT96283A (pt) 1991-09-30
DE69001240D1 (de) 1993-05-06
DE69001240T2 (de) 1993-08-05
JPH04210632A (ja) 1992-07-31
CA2033038A1 (en) 1991-06-22
EP0434094A1 (en) 1991-06-26
IE64870B1 (en) 1995-09-20
DK0434094T3 (da) 1993-08-16
GR3008320T3 (es) 1993-09-30
ATE87614T1 (de) 1993-04-15
IE904627A1 (en) 1991-07-17
EP0434094B1 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
IL85746A0 (en) Preparation of t cells and t cell membrane for use in autoimmune diseases
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
TW283645B (es)
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
FI844510L (fi) Ensym-resistenta immunsystemet modulerande peptider.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DK0668769T3 (da) Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
DE69430951D1 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
DK90089D0 (da) Hudbehandlingspraeparat
RU92016277A (ru) Микробиоциды
ATE78171T1 (de) Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien.
ATE76579T1 (de) Interferon-zusammensetzungen.
ES2054207T3 (es) Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores.
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
NO893224D0 (no) Fremgangsmaate for anrikning av vann med oksygen.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DK320589D0 (da) Fremgangsmaade til hindring af vaekst af aerobe fungi i vandige carbonhydrider
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
ES2044534T3 (es) Un metodo para la preparacion de una composicion tromboliticamente activa.
KR900701322A (ko) 포도필린과 재조합 DNA인간 α인터페론의 배합물로 생식기 우췌를 치료하는 방법
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
DE58909779D1 (de) Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikämie und gicht

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 434094

Country of ref document: ES